Physician in the Loop: Internal Medicine Transistor (https://transistor.fm) https://feeds.transistor.fm/physician-in-the-loop-internal-medicine The week's innovation news in internal medicine for internists, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/internal-medicine/. Read by AI voices. Nomad Medical Group, PLLC 03dad560-d9b4-5395-b078-af29731bc979 yes en Sun, 18 Oct 2026 03:43:29 -0600 Sun, 18 Oct 2026 03:44:01 -0600 https://physicianintheloop.org/specialties/internal-medicine/ https://img.transistorcdn.com/acKElumaqXlj_Mp_a14kQd9b8NaJfK-3hvamWb3CtJw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNWZk/MTU4NGQ1NzcxOGIw/Mzg0NzQ2NDcyOWM5/MjUwOC5qcGc.jpg Physician in the Loop: Internal Medicine https://physicianintheloop.org/specialties/internal-medicine/ episodic Nomad Medical The week's innovation news in internal medicine for internists, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/internal-medicine/. Read by AI voices. The week's innovation news in internal medicine for internists, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. internal medicine, internal medicine news, innovation, medicine, physicians, AI in medicine, weekly briefing Ryan Gillum No No Weekly Briefing for October 11 to 17, 2026 2 2 Weekly Briefing for October 11 to 17, 2026 full 7b2d8876-ba45-46c9-b07f-770049ff334a https://share.transistor.fm/s/e3fbc842 A JAMA study of 271 million queries to the OpenEvidence AI platform found internal medicine physicians had a use ratio of 1.88, above average, researchers from Mass General Brigham and Harvard Medical School reported. The American Medical Association (AMA) released a governance framework for agentic AI that takes on clinical functions, and a primary care trial tied an electronic health record tool to fewer falls in older adults.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/internal-medicine/2026-10-11/

Get this roundup by email, free

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> A JAMA study of 271 million queries to the OpenEvidence AI platform found internal medicine physicians had a use ratio of 1.88, above average, researchers from Mass General Brigham and Harvard Medical School reported. The American Medical Association (AMA) released a governance framework for agentic AI that takes on clinical functions, and a primary care trial tied an electronic health record tool to fewer falls in older adults.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/internal-medicine/2026-10-11/

Get this roundup by email, free

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> Sun, 18 Oct 2026 03:43:29 -0600 Nomad Medical Nomad Medical 188 JAMA study ranks internists among top OpenEvidence AI users; AMA issues framework for agentic AI; EHR tool trims falls in older adults JAMA study ranks internists among top OpenEvidence AI users; AMA issues framework for agentic AI; EHR tool trims falls in older adults Internal medicine,physicians,innovation,AI in medicine,weekly briefing No Weekly Briefing for September 28 to October 4, 2026 1 1 Weekly Briefing for September 28 to October 4, 2026 full 77f18c48-9686-419c-9e10-a098d712bb48 https://share.transistor.fm/s/b93a2416 Retatrutide given weekly cut mean body weight 25.0% at the highest dose over 80 weeks in adults with obesity, a phase 3 trial published Sept. 29 in The New England Journal of Medicine reported. A second trial in The Lancet reported 18.8% loss at that dose in adults with obesity and type 2 diabetes. Six physician groups including the American College of Physicians (ACP) criticized statements suggesting AI is better informed than physicians, and the Centers for Medicare & Medicaid Services (CMS) finalized a Part B drug pricing model.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/internal-medicine/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> Retatrutide given weekly cut mean body weight 25.0% at the highest dose over 80 weeks in adults with obesity, a phase 3 trial published Sept. 29 in The New England Journal of Medicine reported. A second trial in The Lancet reported 18.8% loss at that dose in adults with obesity and type 2 diabetes. Six physician groups including the American College of Physicians (ACP) criticized statements suggesting AI is better informed than physicians, and the Centers for Medicare & Medicaid Services (CMS) finalized a Part B drug pricing model.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/internal-medicine/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> Mon, 05 Oct 2026 22:23:20 -0600 Nomad Medical Nomad Medical 240 Retatrutide cuts mean weight 25.0% at top dose; oral orforglipron meets heart safety test; physician groups rebut AI claims Retatrutide cuts mean weight 25.0% at top dose; oral orforglipron meets heart safety test; physician groups rebut AI claims Internal medicine,physicians,medical news,weekly briefing No